Apolipoprotein E Polymorphism in Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis

[1]  S. Gidding,et al.  Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. , 1998, The Journal of pediatrics.

[2]  P. Portincasa,et al.  Cholesterol crystallization in human gallbladder bile: Relation to gallstone number, bile composition, and apolipoprotein E4 isoform , 1998, Hepatology.

[3]  P. Bosma,et al.  Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Annéren,et al.  Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21–q22 , 1997, Human Genetics.

[5]  M. Färkkilä,et al.  Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis. , 1997, Journal of hepatology.

[6]  N. Freimer,et al.  Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC‐1] and Byler syndrome): Evidence for heterogeneity , 1997, Hepatology.

[7]  Paul S. Meltzer,et al.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome , 1997, Nature Genetics.

[8]  Colin C. Collins,et al.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 , 1997, Nature Genetics.

[9]  M. Hadchouel,et al.  Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis , 1997, Hepatology.

[10]  E. Targarona,et al.  Apolipoprotein E polymorphism and gallstones. , 1996, Gastroenterology.

[11]  A. Legrand,et al.  Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity. , 1996, Gastroenterology.

[12]  M. Hadchouel,et al.  Defect of multidrug‐resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis , 1996, Hepatology.

[13]  R. Santer,et al.  Ursodesoxycholic acid: effect on xanthomas in Alagille-Watson syndrome. , 1994, Journal of pediatric gastroenterology and nutrition.

[14]  P. de Knijff,et al.  ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  S. Schwarzenberg,et al.  Clinical and Biochemical Findings in Progressive Familial Intrahepatic Cholestasis , 1994, Journal of pediatric gastroenterology and nutrition.

[16]  E. Powell,et al.  Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism , 1992, Journal of gastroenterology and hepatology.

[17]  K. Einarsson,et al.  Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E‐2/2 phenotype , 1990, European journal of clinical investigation.

[18]  I. Mcdowell,et al.  Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. , 1989, Clinical chemistry.

[19]  P. Whitington,et al.  Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. , 1988, Gastroenterology.

[20]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[21]  C. Fielding,et al.  Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency. , 1982, Metabolism: clinical and experimental.

[22]  S. Sabesin.  Cholestatic lipoproteins--their pathogenesis and significance. , 1982, Gastroenterology.

[23]  B. Grzybowska,et al.  Hypolipemic diet effect on lipoprotein profile in patients with hypercholesterolaemia and mixed hyperlipidaemia in relation to apo E phenotype , 1999 .

[24]  M. Jonas,et al.  Clinical and biochemical findings in progressive familial intrahepatic cholestasis: Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. J Pediatr Gastroenterol Nutr 1994; 18: 134–141 , 1995 .

[25]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.